Scotland testing COVID-19 therapy to boost immune response early in the infection


TC BioPharm, a Scottish biotech firm, has won approval to test an experimental T-cell injection therapy to fight COVID-19 by boosting the immune system early in a coronavirus infection, the Financial Times reports. The six-month trial in Edinburgh will involve harvesting T-cells from healthy people, cultivating a large number of the cells in a lab, then injecting the donor cells into hospitalized patients. A large enough infusion could head off the infection before the patient needs to move to intensive care, and even prevent cytokine storms that ravage patients whose body mounts an overly aggressive immune response.
"We have got some evidence that if you kill the virus effectively early on, then [there] should be no reason for the host to have this overwhelming response," Dr. Nik HiraniNik Hirani at Edinburgh University's Center for Inflammation Research tells FT. TC BioPharm founder and CEO Mike Leek said the trial will focus on gamma delta T-cells, the "bully boys" of the immune system. "They circulate in surveillance mode looking for a fight and are in particular attracted to cells that are stressed either by cancer or viral infection, for which they are our first line of defense," he said.
T-cells decrease in number as people get older, so the injections might be especially helpful for elderly patients.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
How generative AI is changing the way we write and speak
In The Spotlight ChatGPT and other large language model tools are quietly influencing which words we use
-
How long can Nato keep Donald Trump happy?
Today's Big Question Military alliance pulls out all the stops to woo US president on his peacemaker victory lap
-
Easy Money: the Charles Ponzi Story – an 'enlightening' podcast
The Week Recommends Apple Original podcast explores the 'fascinating' tale of the man who gave the investment scam its name
-
Economists fear US inflation data less reliable
speed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Crypto firm Coinbase hacked, faces SEC scrutiny
Speed Read The Securities and Exchange Commission has also been investigating whether Coinbase misstated its user numbers in past disclosures
-
Starbucks baristas strike over dress code
speed read The new uniform 'puts the burden on baristas' to buy new clothes, said a Starbucks Workers United union delegate
-
Warren Buffet announces surprise retirement
speed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement
-
Trump calls Amazon's Bezos over tariff display
Speed Read The president was not happy with reports that Amazon would list the added cost from tariffs alongside product prices
-
Markets notch worst quarter in years as new tariffs loom
Speed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
-
Tesla Cybertrucks recalled over dislodging panels
Speed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores